A New Jersey jury has assessed $27.5 million in punitive damages against Merck & Co. for marketing Vioxx without properly warning of its risks. Hours earlier, the jury awarded $20 million in compensatory damages, finding that the painkiller and the failure to warn contributed to the plaintiff's heart attack. The $47.5 million verdict is the largest against Merck in a New Jersey Vioxx trial. A defense lawyer said the multiphase trial structure put the company at a disadvantage, and that it will appeal.
March 14, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Jurors in Atlantic City, N.J., assessed punitive damages of $27.5 million against Merck & Co. for marketing its painkiller Vioxx without properly warning of its significant cardiovascular risks.
The punitive award came late on Monday, hours after the jury found that the drug and the failure to warn contributed to plaintiff Frederick Humeston’s heart attack, which occurred five months before Merck changed the product’s label and three years before the product was taken off the market.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
